Sort
15,273 grants matching “antimicrobial resistance”
Anti-biofilm agents for the treatment of pulmonary infection in cystic fibrosis p
$672,768Angela Marie Pollard · Agile Sciences, Inc. · R42 · FY2014 · AI
Roles of novel cationic lipids in bacterial pathogenesis
$672,729Kelli Lea Palmer · University Of Texas Dallas · R01 · FY2023 · AI
Development of a Designer Proline-rich antimicrobial peptide Chaperone protein inhibitor (DPC) for treating multi-drug resistant bacteremia
$672,647Bryan Hoang · Arrevus, Inc. · R42 · FY2020 · AI
Targeted Clinical Trials for Antimicrobial Resistance
$672,522Theoklis Zaoutis · Children'S Hosp Of Philadelphia · N01 · FY2011 · AI
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
$672,512David M. Lewinsohn · Oregon Health & Science University · R01 · FY2022 · AI
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting
$672,361Gayani Tillekeratne · Duke University · R01 · FY2023 · AI
NeoChip for specific and rapid identification of congenital CMV and neonatal HSV infections on minimal sample volume
$671,761Shelley M Lawrence · University Of California, San Diego · R01 · FY2020 · HD
A Pre-, Peri-, and Post-natal Approach to Understanding the Risk and Mechanisms for Obesity
$671,154Sarah S. Comstock · Michigan State University · R01 · FY2025 · DK
Phenylacetic acid catabolism, a novel stress-response pathway in Acinetobacter baumannii
$671,080Mario Feldman · Washington University · R01 · FY2023 · AI
Project 2: Targeting Gram-positive Cell Envelope Assembly
$671,010Suzanne L. Walker · Harvard Medical School · U19 · FY2022 · AI
Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition
$670,887Patricia Pavlinac · University Of Washington · R01 · FY2021 · HD
Defined microbial communities to prevent and eradicate infection by AMR pathogens
$670,879Robert A Britton · Baylor College Of Medicine · U19 · FY2025 · AI
Clinical factors in aminoglycoside-induced ototoxicity
$670,860Peter S Steyger · Creighton University · R01 · FY2019 · DC
CAREER: Self-organization mechanisms in Myxococcus xanthus swarms
$670,804Oleg A Igoshin · William Marsh Rice University · · FY2009 · BIO
Effect of Microbial Metabolites on Growth of Cryptosporidium
$670,711L David Sibley · Washington University · R01 · FY2021 · AI
Effect of Microbial Metabolites on Growth of Cryptosporidium
$670,711L David Sibley · Washington University · R01 · FY2023 · AI
Effect of Microbial Metabolites on Growth of Cryptosporidium
$670,711L David Sibley · Washington University · R01 · FY2022 · AI
Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease
$670,570M. Javad Aman · Abvacc, Inc. · R01 · FY2023 · AI
Global Transcriptome Analysis of Mucosal Gonoccal Infection
$670,568Caroline A Genco · Tufts University Boston · R01 · FY2017 · AI
Antimicrobial catheters with cell and tissue compatibility
$670,296Kennard M Brunson · Wynnvision, Llc · R44 · FY2016 · DK
Immune Mechanisms of Disease Resistance in Amphibian Skin
$670,207Louise A Rollins-Smith · Vanderbilt University Medical Center · · FY2005 · BIO
In Vitro Core
$670,175Michael A Hoffman · University Of Wisconsin-Madison · U19 · FY2018 · AI
Mechanisms of post-discharge morbidity and mortality in HIV-infected and HIV-exposed uninfected children
$669,899Judd L. Walson · University Of Washington · R01 · FY2018 · HD
The roles of genes critical for growth in vitro
$669,700Dirk Schnappinger · Harvard School Of Public Health · U19 · FY2016 · AI
Signal-Based Analysis of Clinical Microbiology
$669,434Vecna Technologies, Inc. · R44 · FY2002 · AI